Ignite Creation Date:
2024-05-06 @ 7:42 PM
Last Modification Date:
2024-10-26 @ 3:11 PM
Study NCT ID:
NCT06100276
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2023-10-20
Brief Title:
Safety Tolerability and Exploratory Efficacy Study of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Sclerosis SOD1-ALS
Sponsor:
UniQure Biopharma BV
Organization:
UniQure Biopharma BV
Organization Data
Organization:
UniQure Biopharma BV
Class:
INDUSTRY
Study ID:
AMT-162-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
UniQure Biopharma BV
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None